EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.862
https://www.valueinhealthjournal.com/article/S1098-3015(22)03066-2/fulltext
Section Title :
Section Order : 10405
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03066-2&doi=10.1016/j.jval.2022.09.862
HEOR Topics :
Tags :
Regions :